PSAMP
RNAM

P. Schoenfeld Asset Management (PSAM)’s Avidity Biosciences RNAM Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-84,700
Closed -$6.11M – 47
2025
Q4 		$6.11M Buy
+84,700
New +$5.47M 2.16% 22

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s RNAM Position: Q1 2026 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 84,700 shares — an estimated $6.11M sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $6.11M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • P. Schoenfeld Asset Management (PSAM) reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • P. Schoenfeld Asset Management (PSAM) sold 84,700 Avidity Biosciences shares in Q1 2026, an estimated $6.11M.
  • P. Schoenfeld Asset Management (PSAM) first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • P. Schoenfeld Asset Management (PSAM)'s Avidity Biosciences position peaked at $6.11M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q1 2026, filed 15 May 2026.